Search

everythinglearnresearchcommunity

for

Search:↓

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.

The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.

During the COVID-19 pandemic, dermatology visits decreased, especially among older patients, patients of color, men, and those with chronic conditions.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

COVID-19 doesn't make alopecia areata worse.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

A global, inclusive approach is needed to address COVID-19 and protect vulnerable groups.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Sebum samples remain stable under various storage conditions, making them suitable for remote and at-home testing.

Effective pre- and post-operative care is crucial for better outcomes in sleeve gastrectomy patients.

Insulin resistance linked to obesity may increase COVID-19 severity.

Platelet-rich plasma (PRP) significantly improves long-lasting post-viral smell dysfunction.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

People who had severe COVID-19 are more likely to experience hair loss.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

COVID-19 might cause gray hair to regain color.

COVID-19 may cause a common type of hair loss called telogen effluvium.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.